Hydrocephalus Shunting Outcomes Review

Shunting Outcomes of Post-Hemorrhagic Hydrocephalus

Protocol Description

This multi-center research study examines the ways in which infants were treated for intraventricular hemorrhage (IVH) and hydrocephalus, also known as post-hemorrhagic hydrocephalus (PHH). Through the program, researchers will compile a comprehensive database about babies diagnosed with and treated for PHH. This is a project of the Hydrocephalus Clinical Research Network, a collaboration of pediatric neurosurgery centers in North America.

Eligibility Criteria

This study is open to infants of both genders up to 180 days of age who have been diagnosed with PHH, which may require treatment through shunting.
Newborns: Up to 180 days old


Participation in the study will not change any clinical, surgical or imaging routines required for the child’s treatment. Parents will be asked for permission to allow the placement of their child’s past, current and future medical record information into the study database, along with copies of medical images taken as part of the treatment and information about surgery and outcomes, for up to 6 months after a procedure is done.
Visits: None beyond standard treatment
Duration: Not applicable

Status: Open for Enrollment

Source(s) of Support

Hydrocephalus Clinical Research Network
National Institutes of Health

Primary Investigator

Ian Pollack, MD

Contact Information

For information, please contact:
Kimberly Diamond, BS, BA